RNAi
December 8, 2025
The Future of Medicine is in Our Genes
Additional human genetics data partnerships are helping scientists identify new drug targets, improving the chances of developing effective medicines
Read More ›
September 30, 2025
How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster
Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines.
Read More ›
August 26, 2025
RNAi Therapeutics: 5 Things You Should Know about this Innovative Class of Medicines
What is RNAi and what do RNAi therapeutics do? Here are 5 things you should know!
Read More ›
February 21, 2025
A New Therapeutic Approach Seeks to Silence Devastating Neurological Diseases
Exploring the potential of RNAi therapeutics to tackle brain diseases with few or no treatments
Read More ›
January 12, 2025
Alnylam's Kevin Fitzgerald, PhD on The Long Run Podcast - The Past and Future of RNAi Ther ...
Alnylam Chief Scientific Officer, Kevin Fitzgerald, PhD recently spoke with Luke Timmerman of The Long Run podcast about the past & future of RNAi therapeutics
Read More ›
September 26, 2024
Confronting the World’s Leading Killer with a New Therapeutic Approach
For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure.
Read More ›
September 12, 2024
RNAi Therapeutics, from Possibility to Patients
The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine.
Read More ›
December 14, 2023
R&D Day 2023 Recap: Following the Science to Deliver on the Promise of RNAi Therapeutics
During our 2023 R&D Day, our leadership discussed several exciting innovations and provided a look ahead at the rapid growth and evoltuion of our pipeline.
Read More ›
August 9, 2023
RNAi Therapeutics on the European Pharmaceutical Review Podcast
Paul Nioi, PhD, VP of Discovery and Translational Research discussed RNAi therapeutics on the The European Medical Review Podcast.
Read More ›
March 16, 2023
Alnylam's Paul Nioi, PhD on The Genetics Podcast: Using Genetics in Drug Target Discovery
Paul Nioi, PhD, VP of Discovery and Translational Research and Head of Alnylam Human Genetics recently spoke with Dr. Patrick Short on The Genetics Podcast.
Read More ›
